This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Universal Health Services' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Universal Health Services Inc. (UHS)

Q1 2012 Results Earnings Call

April 27, 2012 9:00 AM ET


Steve Filton – Chief Financial Officer

Alan Miller – Chief Executive Officer


Bryan Sekino – Barclays

Tom Gallucci – Lazard Capital

Darren Lehrich – Deutsche Bank

Ralph Giacobbe – Credit Suisse

A.J. Rice - UBS

Gary Lieberman – Wells Fargo

Gary Taylor – Citigroup

Kevin Fishbeck – Bank of America

Todd Corsair – UBS

Whit Mayo – Robert Baird

Adam Feinstein – Barclays

Frank Morgan – RBC Capital Markets



Good morning. My name is Christine, and I’ll be your conference operator. At this time, I would like to welcome everyone to the UHS First Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. (Operator Instructions)

Thank you. I will now turn the conference over to Mr. Steve Filton, CFO.

Steve Filton

Thank you and good morning. Alan Miller, our CEO is also joining us this morning. Welcome to this review of Universal Health Services’ results for the first quarter ended March 31, 2012.

During this conference call, Alan and I will be using words such as believes, expects, anticipates, estimates, and similar words that represent forecast, projections, and forward-looking statements.

For anyone not familiar with the risks and uncertainties inherent in these forward-looking statements, I recommend a careful reading of the section on risk factors and forward-looking statements and risk factors in our Form 10-K for the year ended December 31, 2011.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,895.06 +104.87 0.62%
S&P 500 1,992.15 +12.23 0.62%
NASDAQ 4,780.6930 +32.3320 0.68%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs